Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesCurrent DebtDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMS) Non-Current Debt: 2009-2024

Historic Non-Current Debt for Fresenius Medical Care AG (FMS) over the last 3 years, with Dec 2020 value amounting to $413.7 million.

  • Fresenius Medical Care AG's Non-Current Debt rose 7.96% to $7.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 billion, marking a year-over-year increase of 7.96%. This contributed to the annual value of $6.7 billion for FY2024, which is 11.14% down from last year.
  • Fresenius Medical Care AG's Non-Current Debt amounted to $6.7 billion in FY2024, which was down 11.14% from $7.5 billion recorded in FY2023.
  • Fresenius Medical Care AG's Non-Current Debt's 5-year high stood at $7.9 billion during FY2021, with a 5-year trough of $6.7 billion in FY2024.
  • Over the past 3 years, Fresenius Medical Care AG's median Non-Current Debt value was $7.5 billion (recorded in 2023), while the average stood at $7.3 billion.
  • As far as peak fluctuations go, Fresenius Medical Care AG's Non-Current Debt decreased by 7.82% in 2019, and later increased by 1.26% in 2020.
  • MRY analysis of 3 years shows Fresenius Medical Care AG's Non-Current Debt stood at $454.6 million in 2018, then fell by 7.82% to $419.0 million in 2019, then fell by 1.26% to $413.7 million in 2020.
  • Its Non-Current Debt was $6.7 billion in FY2024, compared to $7.5 billion in FY2023 and $7.6 billion in FY2022.